ArticleArchives of medical science : AMS2025
Risk factors for cerebral hyperperfusion syndrome after carotid revascularization: a meta-analysis involving 158,624 participants.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to identify the risk factors associated with cerebral hyperperfusion syndrome (CHS) following carotid revascularization. Material and methods: Comprehensive searches of the Cochrane Library, PubMed, Embase, Web of Science, CBM, CNKI, VIP, and Wanfang databases yielded potentially eligible studies published up to April 30, 2024. We conducted a meta-analysis using RevMan 5.3. Results: Our analysis incorporated ten studies, encompassing 158,624 participants. The results demonstrated that diabetes (OR = 3.16, 95% CI (1.26, 7.93), Conclusions: This investigation elucidated the risk and protective factors for CHS after carotid artery revascularization. Further research and clinical application will aid in refining strategies for the prevention and management of CHS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.